Elizabeth Anderson CFA
Stock Analyst at Evercore ISI
(4.11)
# 1,654
Out of 5,108 analysts
624
Total ratings
53.9%
Success rate
4.9%
Average return
Main Sectors:
Stocks Rated by Elizabeth Anderson CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGL agilon health | Reiterated: Hold | $125 → $105 | $113.77 | -7.71% | 19 | Nov 5, 2026 | |
| CAH Cardinal Health | Reiterated: Buy | $270 | $267.82 | +0.81% | 33 | Nov 5, 2026 | |
| CI The Cigna Group | Reiterated: Hold | $290 | $301.48 | -3.81% | 3 | Nov 5, 2026 | |
| COR Cencora | Reiterated: Buy | $350 → $380 | $339.68 | +11.87% | 30 | Nov 5, 2026 | |
| MCK McKesson | Reiterated: Buy | $1,000 → $1,200 | $1,072.00 | +11.94% | 34 | Nov 5, 2026 | |
| MDLN Medline | Reiterated: Buy | $39 → $44 | $39.76 | +10.66% | 7 | Nov 5, 2026 | |
| NVST Envista Holdings | Reiterated: Buy | $32 → $30 | $24.96 | +20.19% | 29 | Nov 5, 2026 | |
| PRVA Privia Health Group | Reiterated: Buy | $32 → $26 | $23.94 | +8.60% | 19 | Nov 5, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | $330 → $400 | $313.02 | +27.79% | 35 | Nov 4, 2026 | |
| CVS CVS Health | Rated: Buy | $125 → $110 | $81.33 | +35.25% | 40 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $155 → $165 | $159.37 | +3.53% | 48 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $28 | $20.46 | +36.85% | 25 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 → $180 | $201.65 | -10.74% | 24 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $290 → $310 | $264.88 | +17.03% | 24 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $480 | $411.79 | +16.56% | 10 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $480 | $395.72 | +21.30% | 6 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 → $35 | $33.18 | +5.49% | 33 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $28.88 | -3.05% | 18 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 | $363.30 | -6.41% | 17 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $18.95 | +31.93% | 12 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $12.51 | +59.87% | 2 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $14 | $10.09 | +38.75% | 29 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $105 | $115.98 | -9.47% | 9 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $105 | $85.31 | +23.08% | 28 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $7.5 | $9.41 | -20.30% | 30 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $360 | $432.00 | -16.67% | 3 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $210 | $254.74 | -17.56% | 19 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $1.50 | +100.00% | 23 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $8.5 | $0.52 | n/a | 8 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 → $3 | $0.3901 | n/a | 7 | May 6, 2022 |
agilon health
Nov 5, 2026
Reiterated: Hold
Price Target: $125 → $105
Current: $113.77
Upside: -7.71%
Cardinal Health
Nov 5, 2026
Reiterated: Buy
Price Target: $270
Current: $267.82
Upside: +0.81%
The Cigna Group
Nov 5, 2026
Reiterated: Hold
Price Target: $290
Current: $301.48
Upside: -3.81%
Cencora
Nov 5, 2026
Reiterated: Buy
Price Target: $350 → $380
Current: $339.68
Upside: +11.87%
McKesson
Nov 5, 2026
Reiterated: Buy
Price Target: $1,000 → $1,200
Current: $1,072.00
Upside: +11.94%
Medline
Nov 5, 2026
Reiterated: Buy
Price Target: $39 → $44
Current: $39.76
Upside: +10.66%
Envista Holdings
Nov 5, 2026
Reiterated: Buy
Price Target: $32 → $30
Current: $24.96
Upside: +20.19%
Privia Health Group
Nov 5, 2026
Reiterated: Buy
Price Target: $32 → $26
Current: $23.94
Upside: +8.60%
Charles River Laboratories International
Nov 4, 2026
Reiterated: Buy
Price Target: $330 → $400
Current: $313.02
Upside: +27.79%
CVS Health
Nov 4, 2026
Rated: Buy
Price Target: $125 → $110
Current: $81.33
Upside: +35.25%
Oct 30, 2026
Reiterated: Hold
Price Target: $155 → $165
Current: $159.37
Upside: +3.53%
Oct 30, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $20.46
Upside: +36.85%
Oct 28, 2026
Reiterated: Buy
Price Target: $220 → $180
Current: $201.65
Upside: -10.74%
Oct 28, 2026
Reiterated: Buy
Price Target: $290 → $310
Current: $264.88
Upside: +17.03%
Oct 13, 2026
Reiterated: Buy
Price Target: $480
Current: $411.79
Upside: +16.56%
Oct 13, 2026
Reiterated: Buy
Price Target: $480
Current: $395.72
Upside: +21.30%
Sep 29, 2026
Reiterated: Hold
Price Target: $40 → $35
Current: $33.18
Upside: +5.49%
Sep 15, 2026
Reiterated: Buy
Price Target: $28
Current: $28.88
Upside: -3.05%
Sep 11, 2026
Reiterated: Buy
Price Target: $340
Current: $363.30
Upside: -6.41%
Sep 11, 2026
Reiterated: Buy
Price Target: $25
Current: $18.95
Upside: +31.93%
Aug 13, 2026
Reiterated: Buy
Price Target: $20
Current: $12.51
Upside: +59.87%
Aug 7, 2026
Reiterated: Hold
Price Target: $13 → $14
Current: $10.09
Upside: +38.75%
Aug 4, 2026
Reiterated: Buy
Price Target: $45 → $105
Current: $115.98
Upside: -9.47%
Aug 4, 2026
Reiterated: Buy
Price Target: $90 → $105
Current: $85.31
Upside: +23.08%
Jul 30, 2026
Reiterated: Hold
Price Target: $6 → $7.5
Current: $9.41
Upside: -20.30%
May 19, 2026
Upgraded: Buy
Price Target: $360
Current: $432.00
Upside: -16.67%
Apr 20, 2026
Reiterated: Hold
Price Target: $210
Current: $254.74
Upside: -17.56%
Mar 30, 2026
Reiterated: Hold
Price Target: $3
Current: $1.50
Upside: +100.00%
Aug 9, 2022
Reiterated: Hold
Price Target: $9 → $8.5
Current: $0.52
Upside: n/a
May 6, 2022
Reiterated: Hold
Price Target: $2.5 → $3
Current: $0.3901
Upside: n/a